2024 ICD-10-CM Diagnosis Code Q69.9

Polydactyly, unspecified

Short Description:
Polydactyly, unspecified
Is Billable?
Yes - Valid for Submission
Code Navigator:

Code Classification

  • Congenital malformations, deformations and chromosomal abnormalities
    • Congenital malformations and deformations of the musculoskeletal system
      • Polydactyly

Q69.9 is a billable diagnosis code used to specify a medical diagnosis of polydactyly, unspecified. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024. The code is exempt from present on admission (POA) reporting for inpatient admissions to general acute care hospitals.

Unspecified diagnosis codes like Q69.9 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Absent tibia, polydactyly, arachnoid cyst syndrome
  • Arachnoid cyst
  • Autosomal dominant polycystic kidney disease
  • Autosomal dominant preaxial polydactyly, upper back hypertrichosis syndrome
  • Brain malformation, congenital heart disease, postaxial polydactyly syndrome
  • Congenital abnormal shape of rib
  • Congenital anomaly of lobe of ear
  • Congenital dilatation of colon
  • Congenital hypoplasia of tibia
  • Congenital lymphangiectasia
  • Congenital malformation of the meninges
  • Congenital pectus excavatum
  • Cortical blindness
  • Cortical blindness, intellectual disability, polydactyly syndrome
  • Dandy-Walker malformation with postaxial polydactyly syndrome
  • Dandy-Walker syndrome
  • Deformity of sternum
  • Ectrodactyly polydactyly syndrome
  • Finger hyperphalangy, toe anomalies, severe pectus excavatum syndrome
  • Hereditary disorder of lymphatic system
  • Hexadactyly
  • Hirschsprung disease with deafness and polydactyly syndrome
  • Holoprosencephaly and postaxial polydactyly syndrome
  • Holzgreve syndrome
  • Hyperphalangy
  • Hyperphalangy
  • Hypoplastic tibia and postaxial polydactyly syndrome
  • Intellectual disability, polydactyly, uncombable hair syndrome
  • Macroencephaly
  • McKusick Kaufman syndrome
  • Megalencephaly, polymicrogyria, postaxial polydactyly, hydrocephalus syndrome
  • Micromelia
  • Mirror polydactyly, vertebral segmentation and limb defect syndrome
  • Mirror-image polydactyly
  • Mullerian remnant
  • Multinodular goiter
  • Multinodular goiter, cystic kidney, polydactyly syndrome
  • Oliver syndrome
  • Pectus deformity of chest
  • Pectus excavatum
  • Persistent Mullerian derivative with lymphangiectasia and polydactyly syndrome
  • Polydactyly
  • Polydactyly myopia syndrome
  • Postaxial polydactyly, anterior pituitary anomalies, facial dysmorphism syndrome
  • Postaxial polydactyly, dental, vertebral anomalies syndrome
  • Potter's facies
  • Preaxial polydactyly, colobomata, intellectual disability syndrome
  • Renal agenesis
  • Scalp defect postaxial polydactyly syndrome
  • Sensorineural hearing loss of bilateral ears
  • Short rib dysplasia
  • Short rib dysplasia
  • Short rib dysplasia
  • Short rib dysplasia
  • Short rib dysplasia
  • Short rib polydactyly syndrome
  • Short rib polydactyly syndrome Saldino Noonan type
  • Short rib-polydactyly syndrome, Majewski type
  • Split foot
  • Split-foot malformation, mesoaxial polydactyly syndrome
  • Syndactyly, polydactyly, ear lobe syndrome
  • Type III short rib polydactyly syndrome
  • Type IV short rib polydactyly syndrome

Clinical Information

  • Polydactyly-. a congenital anomaly of the hand or foot, marked by the presence of supernumerary digits.
  • Short Rib-Polydactyly Syndrome-. a syndrome inherited as an autosomal recessive trait and incompatible with life. the main features are narrow thorax, short ribs, scapular and pelvic dysplasia, and polydactyly.
  • Smith-Lemli-Opitz Syndrome-. an autosomal recessive disorder of cholesterol metabolism. it is caused by a deficiency of 7-dehydrocholesterol reductase, the enzyme that converts 7-dehydrocholesterol to cholesterol, leading to an abnormally low plasma cholesterol. this syndrome is characterized by multiple congenital abnormalities, growth deficiency, and intellectual disability.
  • Bilateral Renal Agenesis-. a congenital abnormality characterized by the absence of both kidneys.
  • Renal Agenesis-. a congenital abnormality characterized by the absence of one or both kidneys.
  • Unilateral Renal Agenesis|Congenital Single Kidney|Congenital Solitary Kidney|Congenital Solitary Kidney-. a congenital abnormality characterized by the presence of only one kidney.
  • Multinodular Goiter-. nodular goiter characterized by more than one discrete tissue mass.
  • Non-Toxic Multinodular Goiter|Nontoxic multinodular goiter-. a multinodular goiter that is not associated with changes in thyroid function or malignancy.
  • Thyrotoxicosis with Toxic Multinodular Goiter with Thyrotoxic Crisis|Thyrotoxicosis with toxic multinodular goiter with thyrotoxic crisis-. evidence of thyrotoxicosis with toxic multinodular goiter with thyrotoxic crisis.
  • Thyrotoxicosis with Toxic Multinodular Goiter without Thyrotoxic Crisis|Thyrotoxicosis with toxic multinodular goiter without thyrotoxic crisis-. evidence of thyrotoxicosis with toxic multinodular goiter without thyrotoxic crisis.
  • Cortical Blindness-. visual impairment due to visual cortex dysfunction.
  • Autosomal Dominant Polycystic Kidney Disease-. polycystic kidney disease inherited in an autosomal dominant pattern. symptoms usually appear at middle age and include abdominal pain, hematuria and high blood pressure. patients may develop brain aneurysms and liver cysts.
  • Autosomal Dominant Polycystic Kidney Disease Type 2-. autosomal dominant polycystic kidney disease caused by a mutation in pkd2.
  • Autosomal Dominant Polycystic Kidney Disease Type I-. autosomal dominant polycystic kidney disease caused by a mutation in pkd1.
  • Polycystic Kidney Disease, Infantile Severe, with Tuberous Sclerosis|Autosomal Dominant Polycystic Kidney Disease Type 1 with Tuberous Sclerosis|PKDTS|TSC2-PKD1 Contiguous Gene Deletion Syndrome-. an autosomal dominant condition caused by a contiguous gene deletion involving the pkd1 and tsc2 genes, encoding polycystin-1 and tuberin respectively. it is characterized by polycystic kidneys and tuberous sclerosis.
  • Polycystin-1|Autosomal Dominant Polycystic Kidney Disease Protein 1-. polycystin-1 (4303 aa, ~463 kda) is encoded by the human pkd1 gene. this protein may play a role in protein-protein and protein-carbohydrate interactions during kidney development.

Tabular List of Diseases and Injuries

The following annotation back-references are applicable to this diagnosis code. The Tabular List of Diseases and Injuries is a list of ICD-10-CM codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more.

Inclusion Terms

Inclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
  • Supernumerary digit(s) NOS

Index to Diseases and Injuries References

The following annotation back-references for this diagnosis code are found in the injuries and diseases index. The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10-CM code(s).

Present on Admission (POA)

Q69.9 is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement. Review other POA exempt codes here.

CMS POA Indicator Options and Definitions

POA IndicatorReason for CodeCMS will pay the CC/MCC DRG?
YDiagnosis was present at time of inpatient admission.YES
NDiagnosis was not present at time of inpatient admission.NO
UDocumentation insufficient to determine if the condition was present at the time of inpatient admission.NO
WClinically undetermined - unable to clinically determine whether the condition was present at the time of inpatient admission.YES
1Unreported/Not used - Exempt from POA reporting. NO

Convert to ICD-9-CM Code

Source ICD-10-CM CodeTarget ICD-9-CM Code
Q69.9755.00 - Polydactyly NOS
Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.